A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
Jordan B King, Marisa B Schauerhamer, Brandon K Bellows Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, UT, USA Abstract: Diabetes mellitus is a world-wide epidemic with many long-term complications, with neuropathy being the most common. In particul...
Saved in:
Main Authors: | King JB (Author), Schauerhamer MB (Author), Bellows BK (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
by: Kalpajit Dutta, et al.
Published: (2016) -
Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis
by: Juan José Valenzuela-Fuenzalida, et al.
Published: (2024) -
A comparative double-blind randomized study on the effectiveness of Duloxetine and Gabapentin on painful diabetic peripheral polyneuropathy
by: Majdinasab N, et al.
Published: (2019) -
Efficacy of Pregabalin and Duloxetine in Patients with Painful Diabetic Peripheral Neuropathy (PDPN): A Multi-Centre Phase IV Clinical Trial-BLOSSOM
by: Martin Rakusa, et al.
Published: (2023) -
Tapentadol extended release in the management of peripheral diabetic neuropathic pain
by: Vadivelu N, et al.
Published: (2015)